Home > News By Company > RNCOS
RNCOS Releases a New Report - Insulin Delivery Systems Market Analysis (2008-2012)
RNCOS has recently added a new Market Research Report titled, “Insulin Delivery Systems Market Analysis (2008-2012)” to its report gallery. The report provides extensive information and rational analysis on the global insulin market.
(EMAILWIRE.COM, August 25, 2009 ) New Delhi, India - RNCOS has recently added a new Market Research Report titled, “Insulin Delivery Systems Market Analysis (2008-2012)” to its report gallery. The increasing number of diabetes patients globally is proving a boon for diabetes drugs market. The number of diabetic patients in the world is estimated to reach more than 250 Million in 2008. The governments worldwide are taking initiatives on various research and development projects in order to improve drug delivery techniques. This may be beneficial in terms of growing consumer base in developing countries like India and China. The main requirement of present market is to develop efficient delivery methods at low cost and this may change the scenario of the industry.
Our recent research study, "Insulin Delivery Systems Market Analysis (2008-2012)”, states that currently the insulin market is characterized by emergence of new drug delivery devices with improved technology and this trend is likely to continue in next few years also. As a result, global insulin market is forecasted to grow at a CAGR of around 15% during 2010-2012. Anticipating the future growth, pharma giants are making investments in active R&D to increase their market share.
Our report highlights that the insulin market, driven by the increasing prevalence of diabetes, is presently witnessing robust double-digit growth, thus pushing strong demand for insulin delivery devices. Most of the insulin today is available in injectable form through syringes, pens, pumps and needle-free devices; however, the pain and inconvenience caused by most of these devices are driving pharmaceutical companies to discover other ‘painless’ modes of insulin delivery, particularly oral methods. But, on the other hand, a low cost factor is also playing a major part in success of new drug delivery methods.
The report provides extensive information and rational analysis on the global insulin market as well as insulin delivery methods. Thus, it provides valuable information to pharmaceutical and biotech companies and investors looking to enter this market. Analysis and statistics regarding market size, growth, share, regulatory environment and trends in technology development have been thoroughly analyzed in the report to provide clients a comprehensive overview of the market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM207.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Our recent research study, "Insulin Delivery Systems Market Analysis (2008-2012)”, states that currently the insulin market is characterized by emergence of new drug delivery devices with improved technology and this trend is likely to continue in next few years also. As a result, global insulin market is forecasted to grow at a CAGR of around 15% during 2010-2012. Anticipating the future growth, pharma giants are making investments in active R&D to increase their market share.
Our report highlights that the insulin market, driven by the increasing prevalence of diabetes, is presently witnessing robust double-digit growth, thus pushing strong demand for insulin delivery devices. Most of the insulin today is available in injectable form through syringes, pens, pumps and needle-free devices; however, the pain and inconvenience caused by most of these devices are driving pharmaceutical companies to discover other ‘painless’ modes of insulin delivery, particularly oral methods. But, on the other hand, a low cost factor is also playing a major part in success of new drug delivery methods.
The report provides extensive information and rational analysis on the global insulin market as well as insulin delivery methods. Thus, it provides valuable information to pharmaceutical and biotech companies and investors looking to enter this market. Analysis and statistics regarding market size, growth, share, regulatory environment and trends in technology development have been thoroughly analyzed in the report to provide clients a comprehensive overview of the market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM207.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




